Balyasny Asset Management »

Ovid Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $813k 625k 1.30
2023-03-31 $62k 24k 2.58
2022-09-30 $59k 32k 1.85

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Vanguard Group
Affinity Asset Advisors
Acadian Asset Management
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Kennedy Capital Management
Ikarian Capital
Millennium Management
Assenagon Asset Management
Schonfeld Strategic Advisors
Marshall Wace
Wells Fargo & Company

View all funds holding Ovid Therapeutics